Patent 8153703 was granted and assigned to Novartis on April, 2012 by the United States Patent and Trademark Office.
Benzotriazole UV/Visible light-absorbing monomers are disclosed. The UV/Vis absorbers are particularly suitable for use in intraocular lens materials.